NASDAQ
No price data available for this timeframe.
Anika Therapeutics, Inc. (ANIK) has a price/sales ratio of 1.22x as of Friday, May 22, 2026. This represents a 59.45% decrease compared to its 12-month average of 3.01x. The price-to-sales ratio evaluates a company's stock price relative to its revenue, useful for valuing companies with little or no earnings.